COVID-19 vaccines can reduce the risk of heart failure and blood clots after contracting the coronavirus, a new study published in the British Medical Journal has found.

Previous studies have shown that SARS-CoV-2 infection can lead to cardiac and thromboembolic complications, and the risk for infected individuals remains high for a year after illness onset, researchers said. did.

A new study found that while there are still risks, getting the vaccine can reduce the risk of heart failure by up to 55 percent and blood clots by up to 78 percent after the onset of illness.

Using a sample of 10.17 million vaccinated people and 10.39 million unvaccinated people in three European countries, the study found that positive health effects were most pronounced in the 30 days after vaccination, but the longest It turns out that it can last for a year.

The study looked at people who received the Moderna, Pfizer, AstraZeneca and Johnson & Johnson vaccines.

In a new study, doctors say complications from the infection itself are more likely to be associated with vaccination than with the coronavirus vaccine, which has become politicized and controversial despite medical experts encouraging the public to get vaccinated. The results showed that the complications are worse than those that can occur.

“While there has been concern about the risk of myocarditis and other thromboembolic events following vaccination, this analysis shows that the risk of such complications is significantly greater if caused by SARS-CoV-2 infection itself. “It highlighted the high cost,” said Dr. John Brownstein. Boston Children’s Hospital’s chief innovation officer told ABC News.

Study results show that COVID-19 vaccination reduces the risk of heart disease and thromboembolism after infection with COVID-19. Although this effect was more pronounced several weeks after infection, it was “consistent with the known reduction in severity following breakthrough infection compared to unvaccinated SARS-CoV-2 infections.” was found in research.

The Centers for Disease Control and Prevention (CDC) recommends that adults age 65 and older receive the latest vaccinations. The CDC released a report saying the latest vaccine released in the fall was found to be 54% effective at preventing symptomatic infection in adults.